Theravance Biopharma (TBPH) Misses Q2 EPS by 2c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Theravance Biopharma (TBPH) Misses Q2 EPS by 2c, Revenues Miss

Theravance Biopharma, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update

August 6, 2020 4:34 PM EDT

DUBLIN, Aug. 6, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the second quarter ending June 30, 2020. Revenue for the second quarter 2020 was $15.0 million. Operating loss was $72.2 million, or $55.6 million excluding share-based compensation expense. Cash, cash equivalents and marketable securities totaled $438.3 million as of June 30, 2020.

... More